Application of Digital Therapeutic in Lung Cancer Whole Process Management
Investigational drug(s) / intervention(s)
UHealth digital therapeutic
UHealth digital therapeutic: UHealth digital therapeutic is an application that patients can report their symptoms. If the contents that patients fill in reach the threshold, UHealth application will automatic report to doctor and the doctor will give medical advisement through UHealth digital therapeutic application.
Study summary
This trial will randomize patients into two groups, the treatment group will use the digital therapeutic application named 'UHealth' for the whole process management and the control group will use regular follow-up. The trial aims to look into the difference between quality of life, anxiety/depression index, emergency treatment times, hospital admission rate, treatment compliance, OS, DFS and follow-up cost.
Eligibility
Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients with histologically or cytologically confirmed lung cancer;
* Patients have received surgery, neoadjuvant therapy, adjuvant therapy, radiotherapy or other chemotherapy, such as cytotoxic chemotherapy, targeted therapy and immunotherapy;
* ECOG (Performance status) 0-1;
* Patients aged \> 18 years and \< 70 years;
* The patients themselves or their family members are familiar with mobile and internet;
Exclusion Criteria:
* Patients have disease progression in the screening period;
* Patients with symptomatic brain metastasis;
* Patients with dementia, schizophrenia or other psychological diseases that may affect the cognitive behavior;
* Other medical, mental or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or understand the patient information;
* Women who are pregnant or in the period of breastfeeding.
Primary outcome measure(s)
The quality of life after 6 months follow-up — From enrollment to 6 months after follow-up The evaluation of quality of life is based on FACT questionnaire (Version 4.0)
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.